Fresenius 4Q Net Profit Declines; Confirms Preliminary Guidance
By Cecilia Butini
Fresenius SE & Co. said Tuesday that its net profit declined
slightly in the fourth quarter of 2020 on mostly flat sales, and
confirmed its previously reported guidance for 2021.
The German healthcare company reported a profit of 494 million
euros ($600.6 million) for the quarter before special items, down
from EUR506 million the previous year, it said. Sales came in flat
at EUR9.3 billion, Fresenius said.
The figures are within company guidance, Fresenius said, as it
had previously reported in a preliminary statement.
For 2021, the company expects a hit from the coronavirus
pandemic as previously reported in preliminary statements. It sees
sales growth in the low to mid-single digit percentage range and
broadly stable net income on year, it said.
Fresenius Medical Care, the company's dialysis division,
reported net income of EUR372 million excluding special items in
the fourth quarter, slightly up from EUR368 million the previous
year, the company said. This meant Fresenius Medical Care achieved
its 2020 targets as previously announced in preliminary
Write to Cecilia Butini at firstname.lastname@example.org
(END) Dow Jones Newswires
February 23, 2021 01:31 ET (06:31 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.